277 related articles for article (PubMed ID: 15694655)
21. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antimicrobial activity of some novel 2-[4-(substituted piperazin-/piperidin-1-ylcarbonyl)phenyl]-1H-benzimidazole derivatives.
Kus C; Sözüdönmez F; Altanlar N
Arch Pharm (Weinheim); 2009 Jan; 342(1):54-60. PubMed ID: 19051196
[TBL] [Abstract][Full Text] [Related]
23. Relationships between the chemical structure of antimycobacterial substances and their activity against atypical strains. Part 14: 3-Aryl-6,8-dihalogeno-2H-1,3-benzoxazine-2,4(3H)-diones.
Waisser K; Hladuvková J; Gregor J; Rada T; Kubicová L; Klimesová V; Kaustová J
Arch Pharm (Weinheim); 1998 Jan; 331(1):3-6. PubMed ID: 9507695
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antimycobacterial activity of a novel series of isonicotinylhydrazide derivatives.
Jaju S; Palkar M; Maddi VS; Ronad P; Mamledesai S; Satyanarayana D; Ghatole M
Arch Pharm (Weinheim); 2009 Dec; 342(12):723-31. PubMed ID: 19899098
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and potent antimicrobial activities of some novel retinoidal monocationic benzimidazoles.
Ates-Alagöz Z; Alp M; Kus C; Yildiz S; Buyukbingöl E; Göker H
Arch Pharm (Weinheim); 2006 Feb; 339(2):74-80. PubMed ID: 16470650
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria.
Carroll J; Draper LA; O'Connor PM; Coffey A; Hill C; Ross RP; Cotter PD; O'Mahony J
Int J Antimicrob Agents; 2010 Aug; 36(2):132-6. PubMed ID: 20547041
[TBL] [Abstract][Full Text] [Related]
27. 1-Aryl-5-benzylsulfanyltetrazoles, a new group of antimycobacterial compounds against potentially pathogenic strains.
Waisser K; Adamec J; Dolezal R; Kaustová J
Folia Microbiol (Praha); 2005; 50(3):195-7. PubMed ID: 16295656
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles.
Shingalapur RV; Hosamani KM; Keri RS
Eur J Med Chem; 2009 Oct; 44(10):4244-8. PubMed ID: 19540630
[TBL] [Abstract][Full Text] [Related]
29. Benzimidazole condensed ring systems. 8 (1). Synthesis of some substituted 1-oxo-1H,5H-pyrido[1,2-a] benzimidazole-4-carbonitriles with anticipated antimicrobial activity.
Badawey EA; Gohar YM
Farmaco; 1992 Apr; 47(4):489-96. PubMed ID: 1388596
[TBL] [Abstract][Full Text] [Related]
30. Antimycobacterial activity of natural and semi-synthetic lignans.
Silva ML; Martins CH; Lucarini R; Sato DN; Pavanb FR; Freitas NH; Andrade LN; Pereira AC; Bianco TN; Vinholis AH; Cunha WR; Bastos JK; Silva R; Da Silva Filho AA
Z Naturforsch C J Biosci; 2009; 64(11-12):779-84. PubMed ID: 20158145
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, X-ray structure and antimycobacterial activity of silver complexes with alpha-hydroxycarboxylic acids.
Cuin A; Massabni AC; Leite CQ; Sato DN; Neves A; Szpoganicz B; Silva MS; Bortoluzzi AJ
J Inorg Biochem; 2007 Feb; 101(2):291-6. PubMed ID: 17125838
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro anti-mycobacterial activity of 5-substituted pyrimidine nucleosides.
Johar M; Manning T; Kunimoto DY; Kumar R
Bioorg Med Chem; 2005 Dec; 13(24):6663-71. PubMed ID: 16140016
[TBL] [Abstract][Full Text] [Related]
33. Assessment of antimycobacterial activity of a series of mainly marine derived natural products.
König GM; Wright AD; Franzblau SG
Planta Med; 2000 May; 66(4):337-42. PubMed ID: 10865450
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluations of novel benzimidazoles as potential antibacterial agents.
He Y; Yang J; Wu B; Risen L; Swayze EE
Bioorg Med Chem Lett; 2004 Mar; 14(5):1217-20. PubMed ID: 14980669
[TBL] [Abstract][Full Text] [Related]
35. Antimycobacterial activity of 3'- and 4'-fluorothiobenzanilides.
Waisser K; Kunes J; Odlerová Z; Roman M; Kubicová L; Horák V
Pharmazie; 1998 Mar; 53(3):193-5. PubMed ID: 9547521
[TBL] [Abstract][Full Text] [Related]
36. Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
Hu L; Kully ML; Boykin DW; Abood N
Bioorg Med Chem Lett; 2009 Jul; 19(13):3374-7. PubMed ID: 19481935
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antimicrobial screening of N-[2-(2/4-substituted phenyl)-1-(5/6 substituted 1H- benzimidazol-2-yl)vinyl]benzamides.
Kaushik D; Khan SA; Chawla G; Panda BP
Acta Pol Pharm; 2012; 69(4):629-36. PubMed ID: 22876605
[TBL] [Abstract][Full Text] [Related]
38. Heterocyclic isosters of antimycobacterial salicylanilides.
Matyk J; Waisser K; Drazková K; Kunes J; Klimesová V; Palát K; Kaustová J
Farmaco; 2005 May; 60(5):399-408. PubMed ID: 15910812
[TBL] [Abstract][Full Text] [Related]
39. [New heterocyclic derivatives of benzimidazole with germicidal activity. III. Synthesis and activity of derivatives of (formyl-5'-furyl-2')-2-benzimidazole with different substitutions at position 5].
Alunni Bistocchi G; De Meo G; Pedini M; Ricci A; Bastianini L; Sposini T; Sbaraglia G; Jacquignon P
Farmaco Sci; 1986 Dec; 41(12):970-83. PubMed ID: 3556571
[TBL] [Abstract][Full Text] [Related]
40. Ring-substituted quinolines. Part 2: Synthesis and antimycobacterial activities of ring-substituted quinolinecarbohydrazide and ring-substituted quinolinecarboxamide analogues.
Monga V; Nayyar A; Vaitilingam B; Palde PB; Jhamb SS; Kaur S; Singh PP; Jain R
Bioorg Med Chem; 2004 Dec; 12(24):6465-72. PubMed ID: 15556764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
